ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 944

$939K Total Retail Price of All Prescriptions

Rank: 20 out of 944

610 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 16,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 722 640 1 2
METOPROLOL TARTRATE 660 640 2 8
WARFARIN SODIUM 586 539 3 7
AMLODIPINE BESYLATE 562 557 4 5
OMEPRAZOLE 559 498 5 4
POTASSIUM CHLORIDE 532 492 6 15
FUROSEMIDE 473 449 7 6
ATORVASTATIN CALCIUM 435 412 8 13
LISINOPRIL 432 380 9 3
SIMVASTATIN 431 352 10 1
HYDROCODONE-ACETAMINOPHEN 353 274 S3 11 10
METFORMIN HCL 351 294 12 12
PRAVASTATIN SODIUM 345 294 13 17
TRAMADOL HCL 307 242 14 21
PANTOPRAZOLE SODIUM 283 260 15 34
DONEPEZIL HCL 258 258 16 24
CITALOPRAM HBR 257 242 17 19
CRESTOR 257 240 17 28
METOPROLOL SUCCINATE 256 223 19 14
ATENOLOL 251 207 20 11
HYDROCHLOROTHIAZIDE 238 226 21 9
DIGOXIN 203 190 22 39
FENTANYL 201 201 S2 23 57
ALLOPURINOL 187 184 24 22
CYMBALTA 171 97 25 75
BUMETANIDE 167 139 26 104
METFORMIN HCL ER 163 138 27 49
LOVASTATIN 161 142 28 26
LOSARTAN POTASSIUM 161 159 28 16
OXYCODONE-ACETAMINOPHEN 160 115 S2 30 62
PREDNISONE 159 134 31 32
LANTUS 154 145 32 46
TAMSULOSIN HCL 153 144 33 27
CLOPIDOGREL 147 135 34 36
TRAZODONE HCL 145 115 35 45
SERTRALINE HCL 137 131 36 23
KLOR-CON M20 137 124 36 71
ZOLPIDEM TARTRATE 137 93 36 25
CARVEDILOL 136 121 39 30
ENALAPRIL MALEATE 136 122 39 43
NAMENDA 136 126 39 37
GABAPENTIN 135 108 42 18
POLYETHYLENE GLYCOL 3350 130 130 43 41
ISOSORBIDE MONONITRATE ER 128 122 44 52
LOSARTAN-HYDROCHLOROTHIAZIDE 125 103 45 54
NEXIUM 124 76 46 53
GLIPIZIDE ER 111 94 47 89
FENOFIBRATE 109 74 48 58
PLAVIX 108 103 49 55
BYSTOLIC 102 99 50 123
RANITIDINE HCL 101 64 51 42
GLIPIZIDE 99 84 52 51
CARBIDOPA-LEVODOPA 99 82 52 77
ALENDRONATE SODIUM 98 95 54 20
MIRTAZAPINE 93 93 55 35
HYDRALAZINE HCL 93 87 55 87
DIOVAN 93 86 55 38
QUETIAPINE FUMARATE 92 83 58 69
NITROGLYCERIN PATCH 88 88 59 143
GLYBURIDE 85 80 R 60 63
NOVOLOG MIX 70-30 80 75 61 238
CIPROFLOXACIN HCL 79 75 62 90
TRIAMTERENE-HCTZ 77 68 63 33
VENLAFAXINE HCL 76 76 64 210
ADVAIR DISKUS 72 67 65 31
FLUOXETINE HCL 69 54 66 48
ESCITALOPRAM OXALATE 59 50 67 98
NIASPAN 58 49 68 76
LANTUS SOLOSTAR 57 53 69 61
VERAPAMIL ER 56 44 70 120
GLIPIZIDE XL 56 56 70 136
GEMFIBROZIL 55 45 72 72
COMBIVENT 55 43 72 107
PAROXETINE HCL 55 31 72 64
LEVOFLOXACIN 54 51 75 117
CLONIDINE HCL 51 47 76 67
CYCLOBENZAPRINE HCL 51 23 R 76 86
INSULIN SYRINGE 51 51 76 121
IPRATROPIUM-ALBUTEROL 51 51 76 101
RAMIPRIL 50 46 80 144
HUMALOG 50 41 80 109
FLUTICASONE PROPIONATE 50 46 80 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.